Ching-Jen Chen1, Connor Wang2, Thomas J Buell2, Dale Ding3, Daniel M Raper2, Natasha Ironside4, Gabriella M Paisan2, Robert M Starke5, Andrew M Southerland6, Kenneth Liu2, Bradford B Worrall6. 1. Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia, USA. Electronic address: chenjared@gmail.com. 2. Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia, USA. 3. Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA. 4. Department of Neurosurgery, Auckland City Hospital, Auckland, New Zealand. 5. Department of Neurological Surgery, University of Miami, Miami, Florida, USA. 6. Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA.
Abstract
INTRODUCTION: The benefit of endovascular mechanical thrombectomy (EMT) for acute distal occlusions of the middle cerebral artery M2 segment is incompletely defined. The aim of this systematic review is to analyze the recent literature regarding EMT for acute M2 occlusions. METHODS: We reviewed the literature to identify all studies of patients with acute M2 occlusions who underwent EMT that were published after January 1, 2015. Excellent and good outcomes were defined as modified Rankin Scale score of 0-1 and 0-2, respectively, at 3 months. Successful reperfusion was defined as modified Thrombolysis In Cerebral Infarction (mTICI) score of 2b-3. RESULTS: Eight studies, comprising 630 EMT-treated patients with acute M2 occlusions, were included in the analysis. The median National Institute of Health Stroke Scale score ranged from 10 to 16, and the median Alberta Stroke Program Computed Tomography Score ranged from 9 to 10. Excellent and good outcomes at 3-month follow-up were observed in 40% and 62%, respectively, of patients with acute M2 occlusion who underwent EMT, with a mortality of 11%. Successful reperfusion was achieved in 78% of cases. Postprocedural intracerebral hemorrhage (ICH) occurred in 14% of patients, including a symptomatic ICH rate of 5%. CONCLUSIONS: EMT for acute M2 occlusion affords functional independence to most patients, with a modest rate of symptomatic ICH. However, compared with the natural history of distal MCA occlusions, the benefit of M2 thrombectomy using stent retriever or direct aspiration techniques remains unclear.
INTRODUCTION: The benefit of endovascular mechanical thrombectomy (EMT) for acute distal occlusions of the middle cerebral artery M2 segment is incompletely defined. The aim of this systematic review is to analyze the recent literature regarding EMT for acute M2 occlusions. METHODS: We reviewed the literature to identify all studies of patients with acute M2 occlusions who underwent EMT that were published after January 1, 2015. Excellent and good outcomes were defined as modified Rankin Scale score of 0-1 and 0-2, respectively, at 3 months. Successful reperfusion was defined as modified Thrombolysis In Cerebral Infarction (mTICI) score of 2b-3. RESULTS: Eight studies, comprising 630 EMT-treated patients with acute M2 occlusions, were included in the analysis. The median National Institute of Health Stroke Scale score ranged from 10 to 16, and the median Alberta Stroke Program Computed Tomography Score ranged from 9 to 10. Excellent and good outcomes at 3-month follow-up were observed in 40% and 62%, respectively, of patients with acute M2 occlusion who underwent EMT, with a mortality of 11%. Successful reperfusion was achieved in 78% of cases. Postprocedural intracerebral hemorrhage (ICH) occurred in 14% of patients, including a symptomatic ICH rate of 5%. CONCLUSIONS: EMT for acute M2 occlusion affords functional independence to most patients, with a modest rate of symptomatic ICH. However, compared with the natural history of distal MCA occlusions, the benefit of M2 thrombectomy using stent retriever or direct aspiration techniques remains unclear.
Authors: Jan Harsany; Jozef Haring; Matus Hoferica; Miroslav Mako; Pavol Janega; Georgi Krastev; Andrej Klepanec Journal: Interv Neuroradiol Date: 2020-05-12 Impact factor: 1.610
Authors: Kevin Phan; Julian Maingard; Hong Kuan Kok; Adam A Dmytriw; Sourabh Goyal; Ronil Chandra; Duncan Mark Brooks; Vincent Thijs; Hamed Asadi Journal: Neurointervention Date: 2018-08-31
Authors: Tao Wang; Shuyang Dong; Mei Zhang; Chuangqing Yu; Min Xue; Anran Chen Journal: Evid Based Complement Alternat Med Date: 2022-07-30 Impact factor: 2.650
Authors: Adam de Havenon; Ana Paula Narata; Aymeric Amelot; Jeffrey L Saver; Hormozd Bozorgchami; Heinrich Paul Mattle; Marc Ribo; Tommy Andersson; Osama O Zaidat Journal: J Neurointerv Surg Date: 2020-11-20 Impact factor: 5.836
Authors: Shao Ju Shao; Guo Zhen Zhang; Long Zhao; Fa Rong Huo; Hong Bin Ma; Ling Zhu; Zhi Qi Yang; Rong Yin Journal: Medicine (Baltimore) Date: 2020-07-24 Impact factor: 1.817